Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection

The SARS-CoV-2 Omicron variant evades most currently approved neutralizing antibodies (nAbs) and caused drastic decrease of plasma neutralizing activity elicited by vaccination or prior infection, urging the need for the development of pan-variant antivirals. Breakthrough infection induces a hybrid...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yu, Zhang, Guangshun, Yang, Qi, Xie, Xiaowei, Lu, Yang, Cheng, Xuelian, Wang, Hui, Liang, Jingxi, Tang, Jielin, Gao, Yuxin, Shang, Hang, Dai, Jun, Shi, Yongxia, Zhou, Jiaxi, Zhou, Jun, Guo, Hangtian, Yang, Haitao, Qi, Jianwei, Liu, Lijun, Ma, Shihui, Zhang, Biao, Huo, Qianyu, Xie, Yi, Wu, Junping, Dong, Fang, Zhang, Song, Lou, Zhiyong, Gao, Yan, Song, Zidan, Wang, Wenming, Sun, Zixian, Yang, Xiaoming, Xiong, Dongsheng, Liu, Fengjiang, Chen, Xinwen, Zhu, Ping, Wang, Ximo, Cheng, Tao, Rao, Zihe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267556/
https://www.ncbi.nlm.nih.gov/pubmed/37322000
http://dx.doi.org/10.1038/s41467-023-39267-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267556/
https://www.ncbi.nlm.nih.gov/pubmed/37322000
http://dx.doi.org/10.1038/s41467-023-39267-x

Ejemplares similares